The State of Texas Attorney General Takes Legal Action Against Tylenol Producers Over Autism Spectrum Assertions
Texas Attorney General Paxton is taking legal action against the manufacturers of Tylenol, alleging the corporations hid alleged dangers that the medication presented to pediatric cognitive development.
This legal action arrives a month after Former President Trump advocated an unverified association between consuming acetaminophen - alternatively called paracetamol - during pregnancy and autism in children.
Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever recommended for women during pregnancy, and Kenvue, which now manufacturers it.
In a statement, he stated they "misled consumers by making money from suffering and promoting medication ignoring the dangers."
The company asserts there is insufficient reliable data connecting Tylenol to autism.
"These companies lied for decades, knowingly endangering millions to line their pockets," Paxton, from the Republican party, said.
The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the health of US mothers and children."
On its website, Kenvue also mentioned it had "regularly reviewed the relevant science and there is no credible data that demonstrates a established connection between consuming paracetamol and autism."
Groups speaking for doctors and health professionals share this view.
The leading OB-GYN organization has stated paracetamol - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can create significant medical dangers if not addressed.
"In over twenty years of studies on the utilization of paracetamol in gestation, no reliable research has successfully concluded that the consumption of acetaminophen in any period of gestation causes brain development issues in offspring," the organization stated.
The court filing cites recent announcements from the Trump administration in claiming the medication is potentially dangerous.
Last month, Trump raised alarms from health experts when he advised women during pregnancy to "fight like hell" not to consume Tylenol when unwell.
Federal regulators then issued a notice that physicians should consider limiting the use of acetaminophen, while also declaring that "a causal relationship" between the medication and autism in young ones has remains unverified.
The Health Department head Kennedy, who oversees the Food and Drug Administration, had promised in April to conduct "comprehensive study program" that would determine the origin of autism in a matter of months.
But authorities advised that identifying a unique factor of autism - considered by experts to be the consequence of a complicated interplay of inherited and surrounding conditions - would be difficult.
Autism spectrum disorder is a category of permanent neurological difference and impairment that influences how persons experience and interact with the world, and is recognized using physician assessments.
In his court filing, Paxton - aligned with the former president who is running for the Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism.
The lawsuit seeks to make the companies "destroy any promotional materials" that asserts Tylenol is reliable for women during pregnancy.
This legal action mirrors the concerns of a assembly of parents of children with autism spectrum disorder and ADHD who took legal action against the producers of Tylenol in two years ago.
A federal judge dismissed the legal action, saying investigations from the parents' expert witnesses was not conclusive.